A new study led by Neal Masia, Vice President of Patient & Health Impact at Pfizer, and Adjunct Professor of Business in the Management Division at Columbia Business School in New York, assessed how changes in childhood vaccine investment impact a country's gross domestic product (GDP). Using the DTP (diphtheria, tetanus and pertussis) as a proxy for vaccination programs generally, the research findings show that improved childhood vaccination rates were associated with economic growth, suggesting a significant and long-term increases in the GDP growth rate.
NEW YORK—When government forces the business sector to “do good,” it hurts the bottom line and actually reduces voluntary efforts to be good corporate neighbors. Those are the findings of research unveiled today by Columbia Business School, which examines the viability of mandatory Corporate Social Responsibility (CSR) as a business practice, finding that enforced activity –efforts by governments to make CSR spending mandatory by law– is a value-decreasing proposition for shareholders, and a disincentive for corporate good behavior.